Abstract: A method for preparing a modified starch as an alternative to hydroxypropyl distarch phosphate, including: (a) evenly mixing a cassava starch with a buffer solution to obtain a starch suspension with desired pH; (b) adding ?-amylase into the starch suspension for enzymolysis of glycosidic bonds followed by deactivation to obtain a first enzymolysis product; (c) adding hexose oxidase into the first enzymolysis product for lactonization of gluco-oligosaccharides followed by deactivation to obtain a second enzymolysis product; and (d) subjecting the second enzymolysis product to centrifugation, washing and freeze drying to obtain an enzymatically-modified cassava starch.

Abstract: This invention relates to using live beneficial bacteria for treating inflammatory bowel disease, such as ulcerative colitis and Crohn's disease.

Abstract: This invention relates to a method of lowering feces toxin levels and treating digestive disorders (e.g., Irritable Bowel Syndrome or diarrhea) with a composition containing a live beneficial bacterium, a prebiotic, or both. This method includes first identifying a subject in need thereof and then administering to the subject an effective amount of the composition. Also within the scope of this invention is a composition including both a live beneficial bacterium and a prebiotic.

Abstract: This invention relates to a method of lowering feces toxin levels and treating digestive disorders (e.g., Irritable Bowel Syndrome or diarrhea) with a composition containing a live beneficial bacterium, a prebiotic, or both. This method includes first identifying a subject in need thereof and then administering to the subject an effective amount of the composition. Also within the scope of this invention is a composition including both a live beneficial bacterium and a prebiotic.

Abstract: This invention relates to using live beneficial bacteria for treating mouth ulcer.

Abstract: This invention relates to using live beneficial bacteria for treating inflammatory bowel disease, such as ulcerative colitis and Crohn's disease.

Abstract: The present invention discloses a method for preparation of live Bacillus coagulans and the use of the bacteria in treatment of ulcerative colitis. The live bacteria are effective in the treatment of experimental ulcerative colitis in rats. They are also used in the clinical treatment of patients suffering from ulcerative colitis and the efficacy and safety are evaluated. The present invention also discloses the formulation and production method of the live bacterial preparation of Bacillus coagulans, the count of live bacterial in the preparation, and dosage form of the preparation. The present invention shows that the live bacterial preparation is effective and safe for treatment of ulcerative colitis, and the stability of said preparation is good and could be stored at room temperature. Patients can take the preparation for a long term without adverse effect.

Abstract: The present invention provides organic single crystal films of less than 20 &mgr;m, and devices and methods of making such films. The crystal films are useful in electro-optical applications and can be provided as part of an electro-optical device which provides strength, durability, and relative ease of manipulation of the mono-crystalline films during and after crystal growth.